In stockFIG — Tesamorelin (10mg)Growth Hormone
Tesamorelin (10mg)
Visceral fat reduction
≥99% purity · HPLC verified
Select Strength
$79per vial · inquiry priced
An FDA-approved GHRH analog indicated for reduction of excess visceral abdominal fat in lipodystrophy.
Retail Price
$79
Molecular Weight
3135.6 Da
Category
Growth Hormone
Primary Benefit
Visceral fat reduction
Sequence
Tyr-DAla-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu
Research Reference
The published record
Structure & Sequence
Tyr-DAla-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu
Molecular Weight
3135.6 Da
Mechanism of Action
Stable GHRH analog stimulating endogenous GH and IGF-1 to preferentially reduce visceral adiposity.
Evidence Base
Clinical trials confirm significant reductions in visceral adipose tissue in HIV-associated lipodystrophy.
Analytical Testing & Storage
Lyophilized: -20°C for 24 months. Reconstituted: 2-8°C, use within 30 days.
